Copyright © 2000 by the European Society of Cardiology.
Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial vs transfemoral arterial access
a Unité de Cardiologie Interventionelle, Clinique Pasteur, Toulouse, France
b Department of Cardiology, The Geelong Hospital, Australia
revised September 13, 1999; accepted September 15, 1999
Abstract
Aims Vascular complications associated with femoral artery access for interventional cardiological procedures may increase morbidity especially in patients receiving anticoagulants, aspirin, ticlopidine and platelet glycoprotein IIb/IIIa receptor inhibitors. The use of radial arterial access has the potential to reduce the incidence of access site bleeding complications. The purpose of this study was to compare outcomes after the radial and femoral approaches in patients treated with the platelet IIb/IIIa inhibitor, abciximab.
Methods and Results One hundred and fifty consecutive patients treated by abciximab underwent angioplasty by the radial or femoral approach in 83 and 67 cases, respectively. Outcome variables were major cardiac events and major access site bleeding at 1-month follow-up. Freedom from major cardiac events at 1-month follow-up occurred in 78 (93·9%) and 63 (94·0%) patients in the radial and femoral groups, respectively (P=0·99). There were no major access site bleeding complications in the radial group, as opposed to five (7·4%) in the femoral group, P=0·04. Postprocedure length of stay, days (3·7±6·0 radial vs 3·7±2·6 femoral, P=0·96) as well as total hospital length of stay (5·0±4·3 radial vs 4·9±3·0 femoral,P =0·72) were similar in both groups.
Conclusion Coronary angioplasty in patients treated by abciximab using the transradial approach is efficacious with fewer major access site complications than with the transfemoral approach.
Key Words: Coronary angioplasty, transradial, complications
f1 Correspondence: Rémi Choussat MD, Unité de Cardiologie Interventionelle, Clinique Pasteur, 45, avenue de Lombez, Toulouse 31076, France.
References
- N Engl J Med. 1994;330:956961
[Abstract/Free Full Text] - Aguirre FV, Topol EJ, Ferguson J. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation. 1995;91:28902892
- Kereiakes M, Kleimann S, Ambrose A. Randomized double-blind, placebo-controlled dose ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high-risk patients undergoing coronary angioplasty. J Am Coll Cardiol. 1996;27:536542[Abstract]
- Ferguson JJ, Kereiakes DJ, Adgey AAJ. Safe use of platelet GP IIb/IIIa inhibitors. Eur Heart J. 1998;19:3139
- Lotan C, Hasin Y, Mosseri M. Trans-radial approach for coronary angiography and angioplasty. Am J Cardiol. 1995;76:164167[CrossRef][ISI][Medline]
- Barbeau G, Carrier G, Ferland S, Letourneau L, Gleeton O, Larivière M. Right trans-radial approach for coronary procedures: Preliminary results. J Invas Cardiol. 1996;8:19D21D
- Kiemeneij F, Laarman GJ. Trans-radial artery Palmaz-Schatz coronary stent implantation: results of a single-center feasibility study. Am Heart J. 1995;130:1421[CrossRef][ISI][Medline]
- Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wicken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol. 1997;29:12691275[Abstract]
- Mann T, Cubeddu G, Bowen J. Stenting in acute coronary syndromes: a comparison of radial versus femoral access sites. J Am Coll Cardiol. 1998;32:572576
[Abstract/Free Full Text] - N Engl J Med. 1997;336:16891696
[Abstract/Free Full Text] - Lancet. 1997;349:14291435[CrossRef][ISI][Medline]
- Lancet. 1998;352:8792[ISI][Medline]
- Chronos N, Vahanian A, Betriu A. Use of abciximab in interventional cardiology. Eur Heart J. 1998;19:3139
- van der Geest RJ, Morris KG, Cusma JT, Reiber JH. Postmortem validation of the automated coronary analysis (ACA) software package. Int J Card Imaging. 1994;10:95102[CrossRef][Medline]
- Popnia J, Saller I, Pichard A. Vascular complications after balloon and new device angioplasty. Circulation. 1993;88:15691578
[Abstract/Free Full Text] - Arnold A. Hemostasis after radial artery cardiac catheterization. J Invas Cardiol. 1996;8:2629
- Gregorini L, Marco J, Fajadet J. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilatation procedures. J Am Coll Cardiol. 1997;29:1320[Abstract]
- Kiemeneij F, Laarman GJ. Percutaneous trans-radial artery approach for coronary stent implantation. Cathet Cardiovasc Diagn. 1993;30:173178[ISI][Medline]
- Benit E, Missault L, Berman T. Brachial, radial or femoral approach for elective Palmaz-Schatz implantation: a randomized comparison. Cathet Cardiovasc Diagn. 1997;41:124130[CrossRef][ISI][Medline]
- Louvard Y, Lefèvre T, Morice M-C. Radial approach: what about the learning curve? Cathet Cardiovasc Diagn. 1997;41:124130[CrossRef][ISI][Medline]
- Nagai S, Abe S, Sato T, Hozawa K, Yuki K, Hanashima K, Tamoike H. Ultrasonic assessment of vascular complications in coronary angiography and angioplasty after transradial approach. Am J Cardiol. 1999;83:180186[ISI][Medline]
- Stella PR, Kiemeneij F, Laarman GH. Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty. Cathet Cardiovasc Diagn. 1997;40:156158[CrossRef][ISI][Medline]
This article has been cited by other articles:
![]() |
F. A. Spencer and P. G. Steg Major bleeding after PCI. Where is our crystal ball? Eur. Heart J., August 2, 2007; 28(16): 1917 - 1919. [Full Text] [PDF] |
||||
![]() |
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. F. Bertrand, R. De Larochelliere, J. Rodes-Cabau, G. Proulx, O. Gleeton, C. Manh Nguyen, J.-P. Dery, G. Barbeau, B. Noel, E. Larose, et al. A Randomized Study Comparing Same-Day Home Discharge and Abciximab Bolus Only to Overnight Hospitalization and Abciximab Bolus and Infusion After Transradial Coronary Stent Implantation Circulation, December 12, 2006; 114(24): 2636 - 2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
R A. Archbold, N. M Robinson, and R. J Schilling Radial artery access for coronary angiography and percutaneous coronary intervention BMJ, August 21, 2004; 329(7463): 443 - 446. [Full Text] [PDF] |
||||
![]() |
P. Agostoni, G. G. L. Biondi-Zoccai, M. L. De Benedictis, S. Rigattieri, M. Turri, M. Anselmi, C. Vassanelli, P. Zardini, Y. Louvard, and M. Hamon Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: Systematic overview and meta-analysis of randomized trials J. Am. Coll. Cardiol., July 21, 2004; 44(2): 349 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S C Eccleshall, M Banks, R Carroll, R Jaumdally, D Fraser, and J Nolan Implementation of a diagnostic and interventional transradial programme: resource and organisational implications Heart, May 1, 2003; 89(5): 561 - 562. [Full Text] [PDF] |
||||
![]() |
H. Emanuelsson Stents, antithrombotic agents and vascular complications. Does site of arterial access make a difference? Eur. Heart J., April 2, 2000; 21(8): 607 - 609. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





